![Stephen Gillies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Gillies
President at
Provenance Biopharmaceuticals Corp.
Profile
Stephen D.
Gillies is the founder of Lexigen Pharmaceuticals Corp.
Dr. Gillies is President & Director at Provenance Biopharmaceuticals Corp.
Dr. Gillies is Senior Advisor at Delos Advisors Ltd. Former positions include Director at Galenea Corp., Apellis Pharmaceuticals, Inc., and Potentia Pharmaceuticals, Inc.; Head-Pre Clinical Oncology Research at Merck KGaA; Vice President-Research at Damon Biotech, Inc.; and Vice President-Research at Abbott Biotech, Inc. Education includes graduate and doctorate degrees from Rutgers State University of New Jersey and an undergraduate degree from the University of Massachusetts.
Stephen Gillies active positions
| Companies | Position | Start |
|---|---|---|
Provenance Biopharmaceuticals Corp.
 Provenance Biopharmaceuticals Corp. BiotechnologyHealth Technology Develops novel therapeutics for cancer | President | - |
Delos Advisors Ltd.
 Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies. | Consultant / Advisor | - |
Former positions of Stephen Gillies
| Companies | Position | End |
|---|---|---|
Damon Biotech, Inc.
 Damon Biotech, Inc. BiotechnologyHealth Technology Manufactures biological products | Chief Tech/Sci/R&D Officer | - |
Abbott Biotech, Inc. | Chief Tech/Sci/R&D Officer | - |
| APELLIS PHARMACEUTICALS, INC. | Director/Board Member | - |
Galenea Corp.
 Galenea Corp. Pharmaceuticals: MajorHealth Technology Develop therapeutics and drugs for central nervous system diseases | Director/Board Member | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Training of Stephen Gillies
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and drug delivery technologies | Health Technology |
Galenea Corp.
Galenea Corp. Pharmaceuticals: MajorHealth Technology Develop therapeutics and drugs for central nervous system diseases | Health Technology |
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. BiotechnologyHealth Technology Develops novel therapeutics for cancer | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Developer of cancer therapy treatments | Commercial Services |
Damon Biotech, Inc.
Damon Biotech, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott Biotech, Inc. | |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies. | Finance |
- Stock Market
- Insiders
- Stephen Gillies
